Tag: ANDA approval
Bioequivalence Studies: What the FDA Requires Generic Drug Manufacturers to Prove
Finnegan O'Sullivan Jan 23 14The FDA requires generic drug manufacturers to prove bioequivalence through rigorous clinical studies that show their product delivers the same active ingredient at the same rate as the brand-name version. This ensures safety, effectiveness, and cost savings for patients.
More Detail